Richard Lee

You should check out the latest BBC Gardners world on Britbox if you like peonies

Now that the policy is out, we've rolled out an updated version of the story.

bsky.app/profile/maxk...

The GLP-1 Saga Continues, And How

GLP-1 agonists continue to be one of the most high-profile pharmaceutical battlegrounds. A look at recent developments:

China’s Biotech Advances Threaten U.S. Dominance, Warns Congressional Report Congress should invest at least $15 billion to support biotech research over the next five years and take other steps to bolster manufacturing in the U.S., the report said.

This!!! I hope someone in Washington is listening

www.wsj.com/tech/biotech...

12 drug candidates debut in San Diego Structures unveiled during first-time disclosures symposium

If you love drug candidates but weren't able to attend the #FirstTimeDisclosures symposium at #ACSSpring2025, check out my story about the session for @cenmag.bsky.social - with lots of cool-looking molecules.
cen.acs.org/acs-news/acs...

Updated Dashboard

jeremymberg.github.io/jeremyberg.g...

Added graphs for training grants (T mechanisms: T15, T32, T34, T35)

This looks (and is) bleak, but the time for most T mechanisms grants is a bit later. See bsky.app/profile/jere...

1/3

A Bifunctional Degrader Reads Out in Phase 3

The first bifunctional protein degrader to deliver Phase III data! It seems to work, but people were definitely expecting more:

CBT rising stars in chemical biology is today, many outstanding talks from junior scientists